Two Sigma Advisers’s cbdMD YCBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-40
Closed -$2.83K 2696
2023
Q1
$2.83K Hold
40
﹤0.01% 2566
2022
Q4
$3.29K Sell
40
-2
-5% -$201 ﹤0.01% 2486
2022
Q3
$3K Sell
42
-7
-14% -$1K ﹤0.01% 2512
2022
Q2
$8K Sell
49
-8
-14% -$1.89K ﹤0.01% 2597
2022
Q1
$21K Buy
+57
New +$19.3K ﹤0.01% 2667

Other funds holding YCBD

Two Sigma Advisers's YCBD Position: Q2 2023 in Review

Two Sigma Advisers sold out of cbdMD (YCBD) in Q2 2023, closing a stake of 40 shares — an estimated $2.83K sold.

Two Sigma Advisers first reported a position in YCBD in Q1 2022 and held it in 5 quarters. The position peaked at $21K in Q1 2022. 20 funds tracked by Wall St. Rank hold YCBD as of Q2 2023.

  • Two Sigma Advisers reported no remaining cbdMD position as of Q2 2023 after selling out during the quarter.
  • Two Sigma Advisers sold 40 cbdMD shares in Q2 2023, an estimated $2.83K.
  • Two Sigma Advisers first reported a position in cbdMD in Q1 2022 and held it in 5 quarters.
  • Two Sigma Advisers's cbdMD position peaked at $21K in Q1 2022.
  • 20 funds tracked by Wall St. Rank held cbdMD as of Q2 2023.

Based on Two Sigma Advisers's 13F filing for Q2 2023, filed 14 Aug 2023.